Oncotelic Therapeutics, Inc. (OTLC)
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications in the United States.
$0.04+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-20.0%
The outlook
Oncotelic Therapeutics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 22% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range22% of the way from its 52-week low to high
Market cap
$17.7M
52-wk high
$0.11
52-wk low
$0.02
50-day avg
$0.05
200-day avg
$0.06
Trailing P/E
0.1